Sex steroid receptor expression and localization in benign prostatic hyperplasia varies with tissue compartment.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Differentiation; research in biological diversity

• Publication date

  2013-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.diff.2013.02.006PMID 23792768PMCID PMC3729928
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Persistent sexual side effects of finasteride: could they be permanent?

  2013cited by this paper
• Selective estrogen receptor modulators regulate stromal proliferation in human benign prostatic hyperplasia by multiple beneficial mechanisms—action of two new agents

  2012cited by this paper
• Persistent sexual side effects of finasteride: could they be permanent?

  2012cited by this paper
• Steroid hormone receptors, matrix metalloproteinases, insulin‐like growth factor, and dystroglycans interactions in prostatic diseases in the elderly men

  2012influential reference
• Testosterone and 17β-estradiol induce glandular prostatic growth, bladder outlet obstruction, and voiding dysfunction in male mice.

  2012cited by this paper
• A Colorful Future for Quantitative Pathology: Validation of Vectra Technology Using Chromogenic Multiplexed Immunohistochemistry and Prostate Tissue Microarrays

  2012cited by this paper
• Male lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH).

  2011cited by this paper
• Potential biomarkers for differentiation of benign prostatic hyperplasia and prostate cancer

  2010cited by this paper
• Obesity. Diabetes

  2010cited by this paper
• A role for epithelial-mesenchymal transition in the etiology of benign prostatic hyperplasia

  2009influential reference
• Protein Expression of Matriptase and its Cognate Inhibitor HAI-1 in Human Prostate Cancer: A Tissue Microarray and Automated Quantitative Analysis

  2009cited by this paper
• Inflammation and epithelial alterations in rat prostate: impact of the androgen to oestrogen ratio.

  2009cited by this paper
• Cancer nucleus: Morphology and beyond

  2009cited by this paper
• Oestrogen and benign prostatic hyperplasia: effects on stromal cell proliferation and local formation from androgen.

  2008cited by this paper
• The role of estrogens and estrogen receptors in normal prostate growth and disease.

  2008cited by this paper
• Prostatic inflammation and obstructive voiding in the adult noble rat: Impact of the testosterone to estradiol ratio in serum

  2008cited by this paper
• Prostatic hormonal carcinogenesis is mediated by in situ estrogen production and estrogen receptor alpha signaling

  2008cited by this paper
• Androgen receptor expression in clinically localized prostate cancer: immunohistochemistry study and literature review.

  2008influential reference
• Urodynamic changes in a noble rat model for nonbacterial prostatic inflammation

  2007cited by this paper
• Occurrence of cell death (apoptosis) in prostatic intra-epithelial neoplasia

  2005influential reference
• Zone-dependent expression of estrogen receptors alpha and beta in human benign prostatic hyperplasia.

  2003influential reference
• The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia.

  2003cited by this paper
• Saw palmetto alters nuclear measurements reflecting DNA content in men with symptomatic BPH: evidence for a possible molecular mechanism.

  2002cited by this paper
• Estrogen receptors alpha and beta in the normal, hyperplastic and carcinomatous human prostate.

  2001influential reference
• Evidence that epithelial and mesenchymal estrogen receptor-alpha mediates effects of estrogen on prostatic epithelium.

  2001cited by this paper
• Apoptosis and nuclear shapes in benign prostate hyperplasia and prostate adenocarcinoma: Comparison with and relation to Gleason score

  1999influential reference
• Serum prostate-specific antigen and prostate volume predict long-term changes in symptoms and flow rate: results of a four-year, randomized trial comparing finasteride versus placebo. PLESS Study Group.

  1999cited by this paper
• Selective estrogen receptor modulators.

  1999cited by this paper
• Serum prostate-specific antigen concentration is a powerful predictor of acute urinary retention and need for surgery in men with clinical benign prostatic hyperplasia. PLESS Study Group.

  1999cited by this paper
• Expression of estrogen receptor in diseased human prostate assessed by non‐radioactive in situ hybridization and immunohistochemistry

  1995cited by this paper
• Changes in serum concentrations of conjugated and unconjugated steroids in 40- to 80-year-old men.

  1994cited by this paper
• Immunohistochemistry and biochemistry in detection of androgen, progesterone, and estrogen receptors in benign and malignant human prostatic tissue

  1992influential reference
• Clinical and experimental studies of benign prostatic hyperplasia.

  1990cited by this paper
• Histological localization of estrogen receptors in normal and diseased human prostates by immunocytochemistry

  1990cited by this paper
• Normal histology of the prostate.

  1988cited by this paper
• The development of human benign prostatic hyperplasia with age.

  1984cited by this paper

• SRD5A2 and emerging therapies in androgen-driven disorders.

  2026cites this paper
• Mechanistic Insights and Clinical Efficacy Assessment of Traditional Chinese Medicine in Benign Prostatic Hyperplasia Therapy

  2025cites this paper
• Tailoring prostate cancer external beam radiotherapy for patients with lower urinary tract symptoms

  2025cites this paper
• Effects of Taraxaci Herba (Dandelion) on Testosterone Propionate-Induced Benign Prostatic Hyperplasia in Rats

  2024cites this paper
• Age-Dependent Effects of Voluntary Wheel Running Exercise on Voiding Behavior and Potential Age-Related Molecular Mechanisms in Mice.

  2024cites this paper
• Enhanced prostatic Esr1+ luminal epithelial cells in the absence of SRD5A2

  2024cites this paper
• Prostatic androgen receptor signaling shows an age-related and lobe-specific alteration in mice

  2024influential citation
• Mechanisms and Efficacy of Chinese Herbal Medicines in Benign Prostatic Hyperplasia

  2024cites this paper
• Cinnamomum cassia and Rosa laevigata Mixture Improves Benign Prostatic Hyperplasia in Rats by Regulating Androgen Receptor Signaling and Apoptosis

  2023cites this paper
• Aging-Related Mitochondrial Dysfunction is Associated with Fibrosis in Benign Prostatic Hyperplasia.

  2023cites this paper
• The effect of acupuncture on oestrogen receptors in rats with benign prostatic hyperplasia.

  2023cites this paper
• Immunohistochemistry analysis of estrogen receptor and androgen receptor in benign prostatic hyperplasia and prostate carcinoma

  2023cites this paper
• Immunohistochemical Study of BCL2 Protein, Oestrogen Receptor Alpha and Oestrogen Receptor Beta Expression in Adenocarcinoma Prostate and Benign Prostatic Hyperplasia

  2021cites this paper
• GV1001 interacts with androgen receptor to inhibit prostate cell proliferation in benign prostatic hyperplasia by regulating expression of molecules related to epithelial-mesenchymal transition

  2021cites this paper
• RNA-binding protein DDX3 mediates posttranscriptional regulation of androgen receptor: A mechanism of castration resistance

  2020cites this paper
• Review of the Roles and Interaction of Androgen and Inflammation in Benign Prostatic Hyperplasia

  2020cites this paper
• Hyperspectral and multispectral imaging in digital and computational pathology: a systematic review [Invited].

  2020cites this paper
• Targeting a fibrotic bottleneck may provide an opening in the treatment of LUTS.

  2019cites this paper
• Cynomorium songaricum Rupr demonstrates phytoestrogenic or phytoandrogenic like activities that attenuates benign prostatic hyperplasia via regulating steroid 5-α-reductase.

  2019cites this paper
• Do mineral and corn oil serve as potential endocrine disruptors in the gerbil prostate?

  2019cites this paper
• Bakuchiol suppresses oestrogen/testosterone-induced Benign Prostatic Hyperplasia development through up-regulation of epithelial estrogen receptor β and down-regulation of stromal aromatase.

  2019cites this paper
• Tissue-specific quantification and localization of androgen and estrogen receptors in prostate Cancer.

  2019cites this paper
• Clinical Trial Outcomes: What Matters to Patients.

  2019cites this paper
• High serum concentration of estradiol may be a risk factor of prostate enlargement in aging male in China

  2018cites this paper
• Letter to the Editor involving in the article “Gene expression of insulin receptor, insulin-like growth factor increases and insulin-like growth factor-binding protein-3 reduces with increase in prostate size in benign prostatic hyperplasia”

  2018cites this paper
• Vanillic acid attenuates testosterone-induced benign prostatic hyperplasia in rats and inhibits proliferation of prostatic epithelial cells

  2017cites this paper
• The anti-hyperplasia, anti-oxidative and anti-inflammatory properties of Qing Ye Dan and swertiamarin in testosterone-induced benign prostatic hyperplasia in rats.

  2017cites this paper
• Magnetic Resonance Imaging and Molecular Characterization of a Hormone-Mediated Murine Model of Prostate Enlargement and Bladder Outlet Obstruction.

  2017cites this paper
• Hormonal Carcinogenesis: The Role of Estrogens

  2017cites this paper
• Prostate cancer xenografts and hormone induced prostate carcinogenesis.

  2017cites this paper
• Serotonin regulates prostate growth through androgen receptor modulation

  2017cites this paper
• Targeting phenotypic heterogeneity in benign prostatic hyperplasia.

  2017cites this paper
• Estradiol promotes epithelial‐to‐mesenchymal transition in human benign prostatic epithelial cells

  2017cites this paper
• Androgenic to oestrogenic switch in the human adult prostate gland is regulated by epigenetic silencing of steroid 5α‐reductase 2

  2017cites this paper
• Effects of Estrogen Receptor β Stimulation in a Rat Model of Non‐Bacterial Prostatic Inflammation

  2017cites this paper
• Immunohistochemical analysis of estrogen receptors in prostate and clinical correlation in men with benign prostatic hyperplasia

  2017cites this paper
• Inflammatory mediators in the development and progression of benign prostatic hyperplasia

  2016cites this paper
• Erratum to: Which play a more important role in the development of large-sized prostates (≥80 ml), androgen receptors or oestrogen receptors? A comparative study

  2016cites this paper
• In Utero and Lactational TCDD Exposure Increases Susceptibility to Lower Urinary Tract Dysfunction in Adulthood.

  2016cites this paper
• Quantitation of Protein Expression and Co-localization Using Multiplexed Immuno-histochemical Staining and Multispectral Imaging.

  2016cites this paper
• İlişki Associations Between Sex Hormones and Lower Urinary Tract Symptoms in Middle-aged Men

  2016influential citation
• The therapeutic effects of docosahexaenoic acid on oestrogen/androgen-induced benign prostatic hyperplasia in rats.

  2016cites this paper
• Differential expression of androgen, estrogen, and progesterone receptors in benign prostatic hyperplasia.

  2016influential citation
• Differential expression of androgen, estrogen, and progesterone receptors in benign prostatic hyperplasia.

  2016cites this paper
• Isolation and analysis of discreet human prostate cellular populations.

  2016cites this paper
• Orta Yaş Erkeklerde Seks Hormonlari ve Alt Üriner Sistem Semptomlari Arasindaki İlişki Associations Between Sex Hormones and Lower Urinary Tract Symptoms in Middle-aged Men

  2016cites this paper
• Estrogens and Male Lower Urinary Tract Dysfunction

  2015cites this paper
• Re-Punching Tissue Microarrays Is Possible: Why Can This Be Useful and How to Do It

  2015cites this paper
• Stromal androgen receptor roles in the development of normal prostate, benign prostate hyperplasia, and prostate cancer.

  2015cites this paper
• Ovariectomy in young prepubertal dairy heifers causes complete suppression of mammary progesterone receptors.

  2015cites this paper
• SIGIRR/TIR8, an important regulator of TLR4 and IL-1R-mediated NF-κB activation, predicts biochemical recurrence after prostatectomy in low-grade prostate carcinomas.

  2015cites this paper
• Which play a more important role in the development of large-sized prostates (≥80 ml), androgen receptors or oestrogen receptors? A comparative study

  2015cites this paper
• Characterization of Fibrillar Collagens and Extracellular Matrix of Glandular Benign Prostatic Hyperplasia Nodules

  2014cites this paper
• Androgen receptor and immune inflammation in benign prostatic hyperplasia and prostate cancer.

  2014cites this paper
• Estrogen receptor-α is a key mediator and therapeutic target for bladder complications of benign prostatic hyperplasia.

  2014cites this paper
• Influence of stromal-epithelial interactions on androgen action.

  2014cites this paper
• CXCL17 Expression Predicts Poor Prognosis and Correlates with Adverse Immune Infiltration in Hepatocellular Carcinoma

  2014cites this paper
• Stromal nodules in benign prostatic hyperplasia: Morphologic and immunohistochemical characteristics

  2014cites this paper
• Analysis and validation of tissue biomarkers for renal cell carcinoma using automated high-throughput evaluation of protein expression.

  2014cites this paper
• Epithelial‐to‐mesenchymal transition and estrogen receptor α mediated epithelial dedifferentiation mark the development of benign prostatic hyperplasia

  2014cites this paper
• Finasteride treatment alters tissue specific androgen receptor expression in prostate tissues

  2014cites this paper
• Correlation between molecular biomarkers and risk factors for the clinical progression of benign prostatic hyperplasia using tissue microarray immunostaining

  2014cites this paper
• Multispectral Imaging

  2014cites this paper